H-CM + small interfering RNA targeting interleukin-8

H-CM + small interfering RNA targeting interleukin-8 is an experimental therapeutic combination used in preclinical research to investigate the role of the HIF-1α/IL-8 axis in esophageal cancer (EC). This combination consists of conditioned medium derived from macrophages cultured under hypoxic conditions (H-CM) and a small interfering RNA (siRNA) designed to silence the expression of Interleukin-8 (IL-8). In the tumor microenvironment, hypoxia induces tumor-associated macrophages (TAMs) to secrete IL-8, which subsequently promotes cancer cell proliferation, metastasis, and the upregulation of PD-L1. By utilizing siRNA to knock down IL-8 within this hypoxic secretome, researchers can disrupt the pro-tumorigenic signaling pathways that drive EC progression. This approach highlights the potential of targeting macrophage-derived cytokines as a strategy for treating esophageal malignancies.

Other names

Hypoxic conditioned medium + IL-8 siRNAH-CM + si-IL-8